Cargando…

2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function

BACKGROUND: High mobility group box 1 protein (HMGB1) is an alarmin following its release by immune cells upon cellular activation or stress. High levels of extracellular HMGB1 play a critical role in impairing the clearance of invading pulmonary pathogens and dying neutrophils in the injured lungs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mao, Gauthier, Alex G., Kennedy, Thomas P., Wang, Haichao, Velagapudi, Uday Kiran, Talele, Tanaji T., Lin, Mosi, Wu, Jiaqi, Daley, LeeAnne, Yang, Xiaojing, Patel, Vivek, Mun, Sung Soo, Ashby, Charles R., Mantell, Lin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283750/
https://www.ncbi.nlm.nih.gov/pubmed/34271850
http://dx.doi.org/10.1186/s10020-021-00334-y
_version_ 1783723266457731072
author Wang, Mao
Gauthier, Alex G.
Kennedy, Thomas P.
Wang, Haichao
Velagapudi, Uday Kiran
Talele, Tanaji T.
Lin, Mosi
Wu, Jiaqi
Daley, LeeAnne
Yang, Xiaojing
Patel, Vivek
Mun, Sung Soo
Ashby, Charles R.
Mantell, Lin L.
author_facet Wang, Mao
Gauthier, Alex G.
Kennedy, Thomas P.
Wang, Haichao
Velagapudi, Uday Kiran
Talele, Tanaji T.
Lin, Mosi
Wu, Jiaqi
Daley, LeeAnne
Yang, Xiaojing
Patel, Vivek
Mun, Sung Soo
Ashby, Charles R.
Mantell, Lin L.
author_sort Wang, Mao
collection PubMed
description BACKGROUND: High mobility group box 1 protein (HMGB1) is an alarmin following its release by immune cells upon cellular activation or stress. High levels of extracellular HMGB1 play a critical role in impairing the clearance of invading pulmonary pathogens and dying neutrophils in the injured lungs of cystic fibrosis (CF) and acute respiratory distress syndrome (ARDS). A heparin derivative, 2-O, 3-O desulfated heparin (ODSH), has been shown to inhibit HMGB1 release from a macrophage cell line and is efficacious in increasing bacterial clearance in a mouse model of pneumonia. Thus, we hypothesized that ODSH can attenuate the bacterial burden and inflammatory lung injury in CF and we conducted experiments to determine the underlying mechanisms. METHODS: We determined the effects of ODSH on lung injury produced by Pseudomonas aeruginosa (PA) infection in CF mice with the transmembrane conductance regulator gene knockout (CFTR(−/−)). Mice were given ODSH or normal saline intraperitoneally, followed by the determination of the bacterial load and lung injury in the airways and lung tissues. ODSH binding to HMGB1 was determined using surface plasmon resonance and in silico docking analysis of the interaction of the pentasaccharide form of ODSH with HMGB1. RESULTS: CF mice given 25 mg/kg i.p. of ODSH had significantly lower PA-induced lung injury compared to mice given vehicle alone. The CF mice infected with PA had decreased levels of nitric oxide (NO), increased levels of airway HMGB1 and HMGB1-impaired macrophage phagocytic function. ODSH partially attenuated the PA-induced alteration in the levels of NO and airway HMGB1 in CF mice. In addition, ODSH reversed HMGB1-impaired macrophage phagocytic function. These effects of ODSH subsequently decreased the bacterial burden in the CF lungs. In a surface plasmon resonance assay, ODSH interacted with HMGB1 with high affinity (K(D) = 3.89 × 10(–8) M) and induced conformational changes that may decrease HMGB1’s binding to its membrane receptors, thus attenuating HMGB1-induced macrophage dysfunction. CONCLUSIONS: The results suggest that ODSH can significantly decrease bacterial infection-induced lung injury in CF mice by decreasing both HMGB1-mediated impairment of macrophage function and the interaction of HMGB1 with membrane receptors. Thus, ODSH could represent a novel approach for treating CF and ARDS patients that have HMGB1-mediated lung injury. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00334-y.
format Online
Article
Text
id pubmed-8283750
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82837502021-07-19 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function Wang, Mao Gauthier, Alex G. Kennedy, Thomas P. Wang, Haichao Velagapudi, Uday Kiran Talele, Tanaji T. Lin, Mosi Wu, Jiaqi Daley, LeeAnne Yang, Xiaojing Patel, Vivek Mun, Sung Soo Ashby, Charles R. Mantell, Lin L. Mol Med Research Article BACKGROUND: High mobility group box 1 protein (HMGB1) is an alarmin following its release by immune cells upon cellular activation or stress. High levels of extracellular HMGB1 play a critical role in impairing the clearance of invading pulmonary pathogens and dying neutrophils in the injured lungs of cystic fibrosis (CF) and acute respiratory distress syndrome (ARDS). A heparin derivative, 2-O, 3-O desulfated heparin (ODSH), has been shown to inhibit HMGB1 release from a macrophage cell line and is efficacious in increasing bacterial clearance in a mouse model of pneumonia. Thus, we hypothesized that ODSH can attenuate the bacterial burden and inflammatory lung injury in CF and we conducted experiments to determine the underlying mechanisms. METHODS: We determined the effects of ODSH on lung injury produced by Pseudomonas aeruginosa (PA) infection in CF mice with the transmembrane conductance regulator gene knockout (CFTR(−/−)). Mice were given ODSH or normal saline intraperitoneally, followed by the determination of the bacterial load and lung injury in the airways and lung tissues. ODSH binding to HMGB1 was determined using surface plasmon resonance and in silico docking analysis of the interaction of the pentasaccharide form of ODSH with HMGB1. RESULTS: CF mice given 25 mg/kg i.p. of ODSH had significantly lower PA-induced lung injury compared to mice given vehicle alone. The CF mice infected with PA had decreased levels of nitric oxide (NO), increased levels of airway HMGB1 and HMGB1-impaired macrophage phagocytic function. ODSH partially attenuated the PA-induced alteration in the levels of NO and airway HMGB1 in CF mice. In addition, ODSH reversed HMGB1-impaired macrophage phagocytic function. These effects of ODSH subsequently decreased the bacterial burden in the CF lungs. In a surface plasmon resonance assay, ODSH interacted with HMGB1 with high affinity (K(D) = 3.89 × 10(–8) M) and induced conformational changes that may decrease HMGB1’s binding to its membrane receptors, thus attenuating HMGB1-induced macrophage dysfunction. CONCLUSIONS: The results suggest that ODSH can significantly decrease bacterial infection-induced lung injury in CF mice by decreasing both HMGB1-mediated impairment of macrophage function and the interaction of HMGB1 with membrane receptors. Thus, ODSH could represent a novel approach for treating CF and ARDS patients that have HMGB1-mediated lung injury. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00334-y. BioMed Central 2021-07-16 /pmc/articles/PMC8283750/ /pubmed/34271850 http://dx.doi.org/10.1186/s10020-021-00334-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Wang, Mao
Gauthier, Alex G.
Kennedy, Thomas P.
Wang, Haichao
Velagapudi, Uday Kiran
Talele, Tanaji T.
Lin, Mosi
Wu, Jiaqi
Daley, LeeAnne
Yang, Xiaojing
Patel, Vivek
Mun, Sung Soo
Ashby, Charles R.
Mantell, Lin L.
2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function
title 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function
title_full 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function
title_fullStr 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function
title_full_unstemmed 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function
title_short 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function
title_sort 2-o, 3-o desulfated heparin (odsh) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring hmgb1-compromised macrophage function
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283750/
https://www.ncbi.nlm.nih.gov/pubmed/34271850
http://dx.doi.org/10.1186/s10020-021-00334-y
work_keys_str_mv AT wangmao 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT gauthieralexg 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT kennedythomasp 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT wanghaichao 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT velagapudiudaykiran 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT taleletanajit 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT linmosi 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT wujiaqi 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT daleyleeanne 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT yangxiaojing 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT patelvivek 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT munsungsoo 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT ashbycharlesr 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction
AT mantelllinl 2o3odesulfatedheparinodshincreasesbacterialclearanceandattenuateslunginjuryincysticfibrosisbyrestoringhmgb1compromisedmacrophagefunction